We included into the custom set three probes for genes expressed in glioma tumors (GFAP, OLIG2 and PMP2), in addition to the CNS HGNET-BCOR marker probes, and performed hybridization in the series of 27 tumors originally diagnosed as HGG and one HGG relapsed sample. The gene discussed is PMP2; the disease is central nervous system cancer.